Tag: bioequivalence

NTI Drugs: The Risks and Reality of Switching Between Generics

Explore the risks of switching between generic NTI drugs. Learn why narrow therapeutic index medications require stricter monitoring and how to avoid dangerous switches.

Guide to Generic Medication Resources for Doctors: Improving Prescribing Confidence

Comprehensive guide for doctors on using FDA and ACP resources to confidently prescribe generic medications, explain bioequivalence, and improve patient adherence.

Psychiatric Medication Combinations: Managing Generic Alternatives and Risks

Psychiatric Medication Combinations: Navigating Generic Alternatives and Risks

Explore the critical nuances of psychiatric medication combinations, focusing on why generic substitutions pose unique risks for patients relying on multi-drug regimens for mental stability.

Generic Drugs: Complete Definition and Core Characteristics

Generic drugs are identical in active ingredients, strength, and effectiveness to brand-name drugs but cost 80-85% less. Approved by the FDA using strict bioequivalence standards, they make up 90% of U.S. prescriptions while costing only 13% of total drug spending.

Medication Reformulations: When Companies Change Drug Formulas

Medication reformulation changes how drugs are made without altering the active ingredient. Learn why companies do it, how it affects patients, and what to watch for when your prescription looks different.